Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

OMKAR PHARMACHEM vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    OMKAR PHARMACHEM ZYDUS LIFESCIENCES OMKAR PHARMACHEM/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 125.3 19.4 644.6% View Chart
P/BV x 2.5 2.3 109.7% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 OMKAR PHARMACHEM   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    OMKAR PHARMACHEM
Mar-21
ZYDUS LIFESCIENCES
Mar-22
OMKAR PHARMACHEM/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs21674 3.1%   
Low Rs16331 4.8%   
Sales per share (Unadj.) Rs0.3149.1 0.2%  
Earnings per share (Unadj.) Rs0.222.7 1.0%  
Cash flow per share (Unadj.) Rs0.229.7 0.7%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs8.6166.1 5.2%  
Shares outstanding (eoy) m10.081,023.74 1.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x68.43.4 2,028.9%   
Avg P/E ratio x83.322.1 376.9%  
P/CF ratio (eoy) x82.916.9 490.2%  
Price / Book Value ratio x2.13.0 70.4%  
Dividend payout %011.0 0.0%   
Avg Mkt Cap Rs m185514,277 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m121,777 0.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3152,652 0.0%  
Other income Rs m02,354 0.0%   
Total revenues Rs m3155,006 0.0%   
Gross profit Rs m034,427 0.0%  
Depreciation Rs m07,130 0.0%   
Interest Rs m11,270 0.0%   
Profit before tax Rs m028,381 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-35,117 -0.1%   
Profit after tax Rs m223,264 0.0%  
Gross profit margin %8.122.6 35.8%  
Effective tax rate %714.718.0 3,964.1%   
Net profit margin %82.015.2 538.1%  
BALANCE SHEET DATA
Current assets Rs m1122,614 0.0%   
Current liabilities Rs m1078,394 0.0%   
Net working cap to sales %-332.129.0 -1,146.5%  
Current ratio x0.11.6 4.7%  
Inventory Days Days12,57293 13,562.1%  
Debtors Days Days36580 457.0%  
Net fixed assets Rs m93144,382 0.1%   
Share capital Rs m1011,024 9.8%   
"Free" reserves Rs m-14168,972 -0.0%   
Net worth Rs m87169,996 0.1%   
Long term debt Rs m03,621 0.0%   
Total assets Rs m94266,996 0.0%  
Interest coverage x0.423.3 1.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x00.6 5.0%   
Return on assets %3.09.2 32.3%  
Return on equity %2.613.7 18.7%  
Return on capital %0.217.1 1.4%  
Exports to sales %00-   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA21,869 0.0%   
Fx inflow Rs m063,065 0.0%   
Fx outflow Rs m021,869 0.0%   
Net fx Rs m041,196 0.0%   
CASH FLOW
From Operations Rs m021,041 0.0%  
From Investments Rs mNA11,544 0.0%  
From Financial Activity Rs mNA-8,683 0.0%  
Net Cashflow Rs m023,729 0.0%  

Share Holding

Indian Promoters % 0.0 74.9 0.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 14.9 -  
FIIs % 0.0 2.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 100.0 25.1 398.0%  
Shareholders   3,561 455,624 0.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare OMKAR PHARMACHEM With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    SANOFI INDIA    



Today's Market

Sensex Tanks 652 Points, Nifty Ends Below 17,800; IndusInd Bank & Bajaj Finserv Top Losers(Closing)

After opening the day on a flat note, Indian share markets turned volatile during the afternoon session and fell hard as selling was seen in banking and auto stocks.